Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

PBD Biotech wins Canadian Innovation Award for Mycobacterial detection technology

PBD Biotech Ltd, a Suffolk, UK-based company, has won the top Innovation award for Crop or Livestock technology at the Ag-in-Motion Expo in Saskatoon, Canada.
  • August 1, 2017
  • Award, International
  • award, Canada

Having won a competition to attend the event as one of only 4 international companies through the HARVEST program operated by the Saskatoon Regional Economic Development Authority (SREDA), PBD’s technology was awarded the top Innovation prize for the entire show.

The company has developed an innovative technology for diagnosing tuberculosis infections in animals that directly and sensitively detects live bacteria. Given the limitations of existing tests for tuberculosis in animals, this technology could have a transformational effect on the industry.

Collecting the award on behalf of the Company was Mr. Robert Lyons, the Director of the company’s North American operations, who said “we are delighted to accept this award given the high quality of other innovations being presented at the event and look forward to working further with SREDA to introduce our technology into the Canadian market.”

Dr Berwyn Clarke, CEO of the Company, added “this is excellent recognition of the potential of our technology to address the problem of mycobacterial infection in agriculture and wildlife. As a result of this event we will be looking to introduce our tests for both Johne’s disease and Bovine TB into this market at the earliest opportunity”.

PBD Biotech has developed a novel and highly accurate method for rapidly detecting the presence of Mycobacteria in blood, milk and other tissues that may have transformational benefits for both food quality assurance and the control of tuberculosis in animals.

This is of particular interest in Canada where there has been a recent outbreak of Bovine TB resulting in culling and quarantining of thousands of animals with significant implications on animal movement and associated economic loss.

Share:

Related posts

Loading...
Mark Hammond, PBD Biotech CEO

Actiphage shortlisted for Vet Record Innovation Award 2021

February 11, 2021
Actiphage, the rapid diagnostic for Bovine TB and Johne's Disease, has been short-listed for the Vet Record Innovation Award 2021. The award is for an innovation that has brought about – or has the potential to bring about – a...
Mark Hammond, PBD Biotech CEO

Actiphage shortlisted for Vet Record Innovation Award 2021

February 11, 2021
Actiphage, the rapid diagnostic for Bovine TB and Johne's Disease, has been short-listed for the Vet Record Innovation Award 2021....
Luis Martin

Actiphage diagnostic for Johne’s Disease gains funding from Canadian Gov

June 9, 2020
Johne’s disease, a wasting condition of cattle, costs the Canadian dairy industry an estimated $90 million a year through loss of production. Now, advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP)...
Luis Martin

Actiphage diagnostic for Johne’s Disease gains funding from Canadian Gov

June 9, 2020
Johne’s disease, a wasting condition of cattle, costs the Canadian dairy industry an estimated $90 million a year through loss...
bury_free_press_business_awards_2019

PBD Biotech’s new TB test wins West Suffolk Award for Innovation

October 14, 2019
PBD Biotech has been awarded The West Suffolk Award for Innovation for its rapid accurate blood test, which, by detecting TB in humans and animals at early stage, will help to eradicate this devastating disease.
bury_free_press_business_awards_2019

PBD Biotech’s new TB test wins West Suffolk Award for Innovation

October 14, 2019
PBD Biotech has been awarded The West Suffolk Award for Innovation for its rapid accurate blood test, which, by detecting...
Actiphage mycobacterial diagnostic

Dairy-Tech Royal Innovation Dairy Award announces Actiphage as finalist

January 31, 2019
PBD Biotech is delighted that its novel Actiphage® testing technology has been shortlisted as a finalist for the Royal Dairy Innovation Award, to be presented at this year’s Dairy-Tech (6 February 2019).
Actiphage mycobacterial diagnostic

Dairy-Tech Royal Innovation Dairy Award announces Actiphage as finalist

January 31, 2019
PBD Biotech is delighted that its novel Actiphage® testing technology has been shortlisted as a finalist for the Royal Dairy...
1 2 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More